-
1.Ueda K, Yanaihara N, Iida Y, Kobayashi R, Kato S, Matsuda Y, Tomita K, Yamamura N, Saito R, Hirose S, Kuroda T, Seki T, Saito M, Takano H, Yamada K, Okamoto A. (in press). Analysis of risk factors for patients with early-stage cervical cancer: A study of 374 patients. Obstet Gynaecol Res.
-
2.Saito M, Odajima S, Ezawa M, IiDA Y, Ueda K, Yanaihara N, Tanabe H, Takano H, Yamada K, Okamoto A. (in press). Neoadjuvant Chemotherapy for Patients With Diaphragmatic Lesions: A Prognostic Postoperative Analysis. in vivo.
-
3.Yanaihara N, Sato C, Ueda K, Okamoto A. (in press). Juvenile ovarian mature teratoma with malignant transformation diagnosed after laparoscopic surgery: a case report. Eur J Gynaecol Oncol.
-
4.Saito M, Odajima S, Yokomizo R, Tabata J, Iida Y, Ueda K, Yanaihara N, Yamada K, Okamoto A. A simple method of quantifying chemotherapy-induced peripheral neuropathy using PainVision PS-2100®. Asia Pac J Clin Oncol. 2020; 16: 80-5.
-
5.Morikawa A, Hayashi T, Shimizu N, Kobayashi M, Taniue K, Takahashi A, Tachibana K, Saito M, Kawabata A, Iida Y, Ueda K, Saito M, Yanaihara N, Tanabe H, Yamada K, Takano H, Nureki O, Okamoto A, Akiyama T. PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma. Oncotarget. 2018; 9: 15266-74.
-
6.Ueda K, Nagayoshi Y, Kawabata A, Kuroda T, Iida Y, Saitou M, Yanaihara N, Sugimoto K, Sakamoto M, Okamoto A. Feasibility of reduced port surgery applying Higuchi's transverse incision. Gynecology and Minimally Invasive Therapy 2017; 6: 12-6.
-
7.Okamoto A, Nagayoshi Y, Kawabata A, Sakamoto M, Ueda K. Higuchi's transverse incision and a modification of this method for minimally invasive surgery. Gynecol Minim Invasive Ther. 2017; 6: 66-8.
-
8.Yokomizo R, Yamada K, Iida Y, Kiyokawa T, Ueda K, Saito M, Yanaihara N, Nakamura M, Okamoto A. Dedifferentiated endometrial carcinoma: A report of three cases and review of the literature. Mol Clin Oncol 2017; 7: 1008-12.
-
9.Iida Y, Tabata J, Yorozu T, Kitai S, Ueda K, Saito M, Yanaihara N, Yamada K, Okamoto A. Polypoid endometriosis of the ovary and müllerianosis of pelvic lymph nodes mimicking an ovarian carcinoma with lymph node metastasis. Int Cancer Conf J. 2017; 6: 145-8.
-
10.Ueda K, Tabata J, Yanaihara N, Nagayoshi Y, Kawabata A, Onota S, Yamamoto R, Iida Y, Sugimoto K, Okamoto A. Laparoscopic conservative surgery for massive ovarian edema with torsion. Gynecology and Minimally Invasive Therapy 2016; 5: 91–3.
-
11.Saitou M, Iida Y, Komazaki H, Narui C, Matsuno K, Kawabata A, Ueda K, Tanabe H, Takakura S, Isonishi S, Sasaki H, Okamoto A. Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancer. Arch Gynecol Obstet 2014; 291: 641-6.
-
12.Morikawa A, Ueda K, Takahashi K, Fukunaga M, Iwashita M, Kobayashi Y, Takechi K, Umezawa S, Terauchi F, Kiguchi K, Aoki D, Nomura H, Yoshikawa H, Satoh T, Jobo T, Fujiwara H, Takei Y, Kamoi S, Terao Y, Isonishi S. Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women: analysis of 41 cases in Japan. Int J Clin Oncol 2014; 19: 1074-9.
-
13.Ueda K, Yamada K, Kiyokawa T, Iida Y, Nagata C, Hamada T, Saito M, Aoki K, Yanaihara N, Takakura S, Okamoto A, Ochiai K, Ohkawa K, Tanaka T. Pilot study of CD147 protein expression in epithelial ovarian cancer using monoclonal antibody 12C3. J Obstet Gynaecol Res 2012; 38: 1211-9.
-
14.Dobashi M, Isonishi S, Morikawa A, Takahashi K, Ueda K, Umezawa S, Kobayashi Y, Iwashita M, Takechi K, Tanaka T. Ovarian cancer complicated by pregnancy: Analysis of 10 cases. Oncol Lett 2012; 3: 577-80.
-
15.Iida Y, Aoki K, Asakura T, Ueda K, Yanaihara N, Takakura S, Yamada K, Okamoto A, Tanaka T, Ohkawa K. Hypoxia promotes glycogen synthesis and accumulation in human ovarian clear cell carcinoma. Int J Oncol 2012; 40: 2122-30.
-
16.Sato T, Isonishi S, Sasaki K, Nozawa E, Maruta T, Sato Y, Morikawa A, Ueda K, Suzuki K, Kitai S, Fukunaga M, Tanaka T. A case of female adnexal tumor of probable Wolffian origin: significance of MRI findings. Int Canc Conf J 2012;1:108-12.
-
17.Shibata S, Marushima H, Asakura T, Matsuura T, Eda H, Aoki K, Matsudaira H, Ueda K, Ohkawa K. Three-dimensional culture using a radial flow bioreactor induces matrix metalloprotease 7-mediated EMT-like process in tumor cells via TGFbeta1/Smad pathway. Int J Oncol 2009; 34: 1433-48.
-
18.Ueda K, Yamada K, Urashima M, Ishibashi Y, Shirai M, Nikaido T, Takahashi H, Okamoto A, Saito M, Yasuda M, Ohkawa K, Tanaka T. Association of extracellular matrix metalloproteinase inducer in endometrial carcinoma with patient outcomes and clinicopathogenesis using monoclonal antibody 12C3. Oncol Rep 2007; 17: 731-5.
-
19.Takakura S, Saito M, Ueda K, Motegi M, Takao M, Yamada K, Okamoto A, Niimi S, Sasaki H, Tanaka T, Ochiai K. Irinotecan hydrochloride (CPT-11) and cisplatin as first-line chemotherapy after initial surgery for ovarian clear cell adenocarcinoma. Int Surg 2007; 92: 202-8.
-
20.Ueda K, Okamoto A, Yamada K, Saito M, Takakura S, Tanaka T, et al. Nonpuerperal inversion of the uterus associated with endometrial cancer: a case report. Int J Clin Oncol 2006;11:153-5.
-
21.Yamada K, Tachibana T, Iida Y, Ueda K, Misawa A, Suzuki N, Takahashi H, Kato H, Kimura E, Yasuda M, Tanaka T, Ishikawa H. Establishment and characterization of JHUCS-1 cell line derived from carcinosarcoma of the human uterus. Hum Cell 2004; 17: 139-44.